StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen restricted Stock Units (RSUs) — Nonvested Shares Outstanding (M shares) (M)

Form 10-K Stock-Based Compensation Note (XBRL)

Latest, FY2025
3.70
Period ended Dec 31, 2025
Change on a year earlier
+5.7%
3.50 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestricted Stock Units (RSUs) — Nonvested Shares Outstanding (M shares) (M)Year on yearSource
FY2025Dec 31, 20253.70+5.7%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20243.50-10.3%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 20233.90+39.3%Form 10-K (filed 2025-02-14) ↗
FY2022Dec 31, 20222.80-6.7%Form 10-K (filed 2024-02-14) ↗
FY2021Dec 31, 202130.0%Form 10-K (filed 2023-02-09) ↗
FY2020Dec 31, 20203-3.2%Form 10-K (filed 2022-02-16) ↗
FY2019Dec 31, 20193.100.0%Form 10-K (filed 2021-02-09) ↗
FY2018Dec 31, 20183.10-8.8%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 20173.40-12.8%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 20163.90-22.0%Form 10-K (filed 2018-02-13) ↗
FY2015Dec 31, 20155–Form 10-K (filed 2017-02-14) ↗

Breakdown

What makes up restricted stock units (rsus) — nonvested shares outstanding (m shares)

Cite this data

StockData. (2026). Amgen Restricted Stock Units (RSUs) — Nonvested Shares Outstanding (M shares) (M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/rsu_nonvest_sh

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.